Elena Santiago Cid

Mrs. Santiago Cid is CEN and CENELEC Director General since 1 January 2010. CEN and CENELEC are two of the three recognized European Standardization Organizations supporting European Policies and Legislation. Moreover, Mrs. Santiago Cid is also Vice-President at the Women4Cyber Foundation.

CEN and CENELEC, recognized Standardization Organizations under EU Law, are leading providers of European Standards that are driven by business and made through a transparent, balanced and consensus-based process in which all relevant stakeholders, including societal interest groups and SMEs are involved. CEN and CENELEC abide by the WTO TBT principles and beyond. They adapt proactively to
new technology and social developments and support European competitiveness, the protection of the environment and sustainable growth for the well-being of citizens and the strengthening of the Single Market.

CEN and CENELEC actively support international standardization and cooperate closely with the International Organization for Standardization (ISO) and the International Electrotechnical Commission (IEC) in order to foster and promote European competitiveness in the global market.

Mrs. Santiago Cid graduated in Electronic Engineering from the Polytechnic University of Madrid and has 25 years’ experience in standardization.

Securing the Future of the U.S. Biopharmaceutical Industry: The Most-Favored-Nation Paradox

By Sujai Shivakumar and Anne Pritchett The Trump administration is pursuing lowering prescription drug costs primarily to end what it describes as “global freeloading” and to ensure U.S. patients pay prices comparable to those in other developed nations. The administration argues that while the United States represents less than 5 percent
Read More

Universities, Patents, and the Future of U.S. Competitiveness

By Shruti Sharma and Chris Borges Universities are among the most powerful engines of U.S. innovation, transforming federal research investments into scientific discoveries that underpin economic growth, technological leadership, and national security. Current law, via the Bayh-Dole Act, allows universities to patent inventions and license them to private companies, with royalties
Read More

How Counterfeit Drugs Threaten U.S. Health and Innovation

By Anne Pritchett According to the Department of Homeland Security, counterfeit drugs “threaten national security and public safety directly when introduced into government and critical infrastructure supply chains, and indirectly if used to generate revenue for transnational criminal organizations.” Furthermore, counterfeit drugs harm pharmaceutical innovation by eroding profitability and investor
Read More